Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! 

China Clinical Trials 2017

Analysis of IND and NDA applications and approvals in China 2011-2017

Download free report on life science investment in China

Cell & Gene Therapy

Stem cell research and commercialization in China...

TCR2 Therapeutics Closes $125 Million B Round for Immunoncology Program
JW, a Juno-WuXi AppTec China JV, Raises $90 Million for CAR-T Drugs
Shanghai's CARsgen Heads Towards IPO with $60 Million Pre-C Round
Nanjing Legend/GenScript Bio and Cancer's Next Big Thing: CAR-T
Cellular Biomedicine Raises $30.6 Million from Sailing Capital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Device China 2018
September 8-9, 2018